Cargando…
Treatment related fluctuation and response to intravenous immunoglobulin therapy in post COVID-19 Guillain-Barre syndrome()
Treatment related fluctuation (TRF) poses a special challenge in the treatment of Guillain-Barre syndrome (GBS). Many cases of GBS following COVID-19 infection have been reported in literature till date, but treatment related fluctuation (TRF) in post COVID-19 GBS has not been reported till date. We...
Autores principales: | Gupta, Subhadeep, Chandra, Atanu, Ray, Biman Kanti, Pandit, Alak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Diabetes India. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361026/ https://www.ncbi.nlm.nih.gov/pubmed/34416468 http://dx.doi.org/10.1016/j.dsx.2021.102246 |
Ejemplares similares
-
Post-Varicella Neurological Complications: A Preliminary Observation from a Tertiary Care Centre of Eastern India
por: Gupta, Subhadeep, et al.
Publicado: (2022) -
Acute aseptic meningitis due to intravenous immunoglobulin therapy in Guillain–Barré syndrome
por: Jain, Rajendra Singh, et al.
Publicado: (2014) -
Give or take? Intravenous immunoglobulin or plasma exchange for Guillain-Barré syndrome
por: Hughes, Richard AC
Publicado: (2011) -
Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome
por: Charra, B, et al.
Publicado: (2009) -
Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy
por: Garcia, Jao Jarro, et al.
Publicado: (2021)